MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaci.2023.05.019

Медицинская библиотека · The Journal of allergy and clinical immunology · 2023

Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.

Greenhawt Matthew, Dribin Timothy E, Abrams Elissa M, Shaker Marcus, Chu Derek K, Golden David B K, Akin Cem, Anagnostou Akterini, ALMuhizi Faisal, Alqurashi Waleed, Arkwright Peter, Baldwin James L, Banerji Aleena, Bégin Philippe, Ben-Shoshan Moshe, Bernstein Jonathan, Bingemann Theresa A, Bindslev-Jensen Carsten, Blumenthal Kim, Byrne Aideen, Cahill Julia, Cameron Scott, Campbell Dianne, Campbell Ronna, Cavender Michael, Chan Edmond S, Chinthrajah Sharon, Comberiati Pasquale, Eastman Jacqueline J, Ellis Anne K, Fleischer David M, Fox Adam, Frischmeyer-Guerrerio Pamela A, Gagnon Remi, Garvey Lene H, Grayson Mitchell H, Isabwe Ghislaine Annie Clarisse, Hartog Nicholas, Hendron David, Horner Caroline C, Hourihane Johnathan O'B, Iglesia Edward, Kan Manstein, Kaplan Blanka, Katelaris Constance H, Kim Harold, Kelso John M, Khan David A, Lang David, Ledford Dennis, Levin Michael, Lieberman Jay A, Loh Richard, Mack Douglas P, Mazer Bruce, Mody Ketan, Mosnaim Gisele, Munblit Daniel, Mustafa S Shahzad, Nanda Anil, Nathan Richard, Oppenheimer John, Otani Iris M, Park Miguel, Pawankar Ruby, Perrett Kirsten P, Peter Jonny, Phillips Elizabeth J, Picard Matthieu, Pitlick Mitchell, Ramsey Allison, Rasmussen Trine Holm, Rathkopf Melinda M, Reddy Hari, Robertson Kara, Rodriguez Del Rio Pablo, Sample Stephen, Sheshadri Ajay, Sheik Javed, Sindher Sayantani B, Spergel Jonathan M, Stone Cosby A, Stukus David, Tang Mimi L K, Tracy James M, Turner Paul J, Vander Leek Timothy K, Wallace Dana V, Wang Julie, Wasserman Susan, Weldon David, Wolfson Anna R, Worm Margitta, Yacoub Mona-Rita

СтатьяПоддержка NIH: внешняя программаОбзорConsensus StatementПеревод в очереди

Аннотация

This guidance updates 2021 GRADE (Grading of Recommendations Assessment, Development and Evaluation) recommendations regarding immediate allergic reactions following coronavirus disease 2019 (COVID-19) vaccines and addresses revaccinating individuals with first-dose allergic reactions and allergy testing to determine revaccination outcomes. Recent meta-analyses assessed the incidence of severe allergic reactions to initial COVID-19 vaccination, risk of mRNA-COVID-19 revaccination after an initial reaction, and diagnostic accuracy of COVID-19 vaccine and vaccine excipient testing in predicting reactions. GRADE methods informed rating the certainty of evidence and strength of recommendations. A modified Delphi panel consisting of experts in allergy, anaphylaxis, vaccinology, infectious diseases, emergency medicine, and primary care from Australia, Canada, Europe, Japan, South Africa, the United Kingdom, and the United States formed the recommendations. We recommend vaccination for persons without COVID-19 vaccine excipient allergy and revaccination after a prior immediate allergic reaction. We suggest against >15-minute postvaccination observation. We recommend against mRNA vaccine or excipient skin testing to predict outcomes. We suggest revaccination of persons with an immediate allergic reaction to the mRNA vaccine or excipients be performed by a person with vaccine allergy expertise in a properly equipped setting. We suggest against premedication, split-dosing, or special precautions because of a comorbid allergic history.

Для цитирования: Greenhawt Matthew, Dribin Timothy E, Abrams Elissa M, Shaker Marcus, Chu Derek K, Golden David B K, Akin Cem, Anagnostou Akterini, ALMuhizi Faisal, Alqurashi Waleed, Arkwright Peter, Baldwin James L, Banerji Aleena, Bégin Philippe, Ben-Shoshan Moshe, Bernstein Jonathan, Bingemann Theresa A, Bindslev-Jensen Carsten, Blumenthal Kim, Byrne Aideen, Cahill Julia, Cameron Scott, Campbell Dianne, Campbell Ronna, Cavender Michael, Chan Edmond S, Chinthrajah Sharon, Comberiati Pasquale, Eastman Jacqueline J, Ellis Anne K, Fleischer David M, Fox Adam, Frischmeyer-Guerrerio Pamela A, Gagnon Remi, Garvey Lene H, Grayson Mitchell H, Isabwe Ghislaine Annie Clarisse, Hartog Nicholas, Hendron David, Horner Caroline C, Hourihane Johnathan O'B, Iglesia Edward, Kan Manstein, Kaplan Blanka, Katelaris Constance H, Kim Harold, Kelso John M, Khan David A, Lang David, Ledford Dennis, Levin Michael, Lieberman Jay A, Loh Richard, Mack Douglas P, Mazer Bruce, Mody Ketan, Mosnaim Gisele, Munblit Daniel, Mustafa S Shahzad, Nanda Anil, Nathan Richard, Oppenheimer John, Otani Iris M, Park Miguel, Pawankar Ruby, Perrett Kirsten P, Peter Jonny, Phillips Elizabeth J, Picard Matthieu, Pitlick Mitchell, Ramsey Allison, Rasmussen Trine Holm, Rathkopf Melinda M, Reddy Hari, Robertson Kara, Rodriguez Del Rio Pablo, Sample Stephen, Sheshadri Ajay, Sheik Javed, Sindher Sayantani B, Spergel Jonathan M, Stone Cosby A, Stukus David, Tang Mimi L K, Tracy James M, Turner Paul J, Vander Leek Timothy K, Wallace Dana V, Wang Julie, Wasserman Susan, Weldon David, Wolfson Anna R, Worm Margitta, Yacoub Mona-Rita. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.. The Journal of allergy and clinical immunology. 2023. DOI: 10.1016/j.jaci.2023.05.019.

Предметные рубрики MeSH

HumansAnaphylaxisCOVID-19COVID-19 VaccinesExcipientsGRADE ApproachHypersensitivity, ImmediateVaccine Excipients
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.